Butyrophenone
Butyrophenone is an organic compound with the chemical formula \(\text{C}_{10}\text{H}_{12}\text{O}\), characterized as a colorless liquid. The structure of butyrophenone consists of a ketone group flanked by a phenyl ring and a butyl chain. This foundational structure has led to the development of various derivatives with significant medical applications, particularly in the field of psychiatry and as antiemetics[1].
Butyrophenone derivatives are known for their role as antipsychotic agents, primarily used in the treatment of psychiatric disorders such as schizophrenia. They function as dopamine receptor blockers, which can influence gastrointestinal peristalsis, induce prolactin release, and serve as antiemetics[2]. The mechanism of action involves the blockade of dopamine receptors, which is crucial for their therapeutic effects in managing symptoms of psychiatric disorders and in controlling nausea and vomiting[2].
Several butyrophenone derivatives have been developed and utilized in clinical practice. Notable examples include:
- Haloperidol: The most widely used classical antipsychotic drug within this class, known for its effectiveness in treating schizophrenia[1].
- Benperidol: Recognized as the most potent commonly used antipsychotic, being approximately 200 times more potent than chlorpromazine[1].
- Lumateperone: An atypical antipsychotic used for managing schizophrenia and bipolar depression[1].
- Droperidol: Utilized as an antiemetic for postoperative nausea and vomiting[1].
These derivatives have been instrumental in advancing the treatment of various psychiatric conditions, offering options for managing symptoms effectively. However, it's important to note that the use of butyrophenone derivatives can be associated with side effects, including sedation, extrapyramidal symptoms, and effects on heart and blood circulation, as observed in studies with Lenperone[3]. Despite these potential side effects, butyrophenones remain a valuable class of medications in the psychiatric field, with ongoing research and clinical trials aimed at understanding their full therapeutic potential and safety profile[3][4].
In summary, butyrophenones and their derivatives play a crucial role in the treatment of psychiatric disorders and as antiemetics, with their mechanism of action primarily involving the blockade of dopamine receptors. Their development has significantly contributed to the field of psychiatry, offering effective treatment options for managing complex conditions such as schizophrenia.
Citations:
[1] https://en.wikipedia.org/wiki/Butyrophenone
[2] https://www.sciencedirect.com/topics/neuroscience/butyrophenone
[3] https://pubmed.ncbi.nlm.nih.gov/561037/
[4] https://pubmed.ncbi.nlm.nih.gov/4479786/
[5] https://www.merriam-webster.com/dictionary/butyrophenone
[6] https://www.sciencedirect.com/topics/medicine-and-dentistry/butyrophenone-derivative
[7] https://journals.sagepub.com/doi/pdf/10.1177/070674377502000626
[8] https://www.sciencedirect.com/science/article/pii/096980439500185G
[9] https://www.sciencedirect.com/topics/medicine-and-dentistry/butyrophenone
[10] https://go.drugbank.com/categories/DBCAT002383
[11] https://pubmed.ncbi.nlm.nih.gov/660119/
[12] https://www.sigmaaldrich.com/US/en/product/mm/841778
[13] https://pubchem.ncbi.nlm.nih.gov/compound/Butyrophenone
[14] https://pubmed.ncbi.nlm.nih.gov/21435315/
[15] https://www.neuro-doc.com/blog/806089-an-unusual-adverse-reaction-with-butyrophenone-therapy
[16] https://www.britannica.com/science/butyrophenone
[17] https://litfl.com/phenothiazines-and-butyrophenones/
[18] https://www.sciencedirect.com/topics/nursing-and-health-professions/butyrophenone
[19] https://link.springer.com/article/10.1007/BF02341263
[20] https://www.wikidoc.org/index.php/Butyrophenone